/Companies

Venclose

San Jose, US · Delaware corporation · 2 known investors

Find your way into Venclose

Sign up to see every warm intro you have to Venclose

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Venclose team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

GV
Greg VislockyNamed on SEC filing
CC
Charles ChonNamed on SEC filing
JTJason Turner
Jason TurnerChief Operating Officer2017–2021Executive Officer, Director at Vantis Vascular
PO
Peter OsborneNamed on SEC filing
JG
Jerry GibsonNamed on SEC filing

Investors · 2

Reported raises · per SEC filings

Form D private placements

$27.1M disclosed across 1 round · 2019

▶$27.1MraisedNov 2019 · 67 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Greg VislockyDirector
  • Charles ChonDirector
  • Jason TurnerExecutive Officer
  • Peter OsborneExecutive Officer, Director
  • Jerry GibsonExecutive Officer, Director
Offering amount
$27.1M
Amount sold
$27.1M
First sale
Jul 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Venclose's investors?
Venclose's investors include SCP Ventures, LLC, Ally Bridge Group.
How much funding has Venclose raised?
Venclose has disclosed $27.1M raised across 1 round.
Where is Venclose headquartered?
Venclose is headquartered in San Jose, US.